GPC3 Protein-VLP, Human, Recombinant

Glypican-3 is a protein ,which is encoded by the GPC3 gene in humans.The protein core of GPC3 consists of two subunits, where the N-terminal subunit has a size of ~40 kDa and the C-terminal subunit is ~30 kDa.Glypican 3 is a potential therapeutic target for treating liver cancer and other cancers. Several therapeutic anti-GPC3 antibodies have been developed.

Pack Size	Availability	Price/USD
100 μg	5 days	$ 1,850.00
500 μg	5 days	$ 7,460.00
1 mg	5 days	$ 12,430.00

Pack Size

Availability

Price/USD

Quantity

100 μg

5 days

$ 1,850.00

500 μg

5 days

$ 7,460.00

1 mg

5 days

$ 12,430.00

Description

Species	Human
Expression System	E. coli
Accession Number	P51654-1
Synonyms	Glypican 3, SGB, SGBS1SDYS, DGSX, OCI-5, OCI5, GTR2-2, GPC3, SGBS1, SGBS, MXR7, SDYS
Construction	Recombinant Human GPC3 Protein-VLP is expressed from E.coli. It contains Gly510-Asn554.[Accession \|P51654-1]
Molecular Weight	The target protein has a predicted MW of 14 kDa.

Endotoxin	Less than 1EU per μg by the LAL method.
Formulation	Supplied as 0.22μm filtered solution in 20mM HEPES, 500mM NaCl, 10% Glycerol, 0.1% Tween20 (pH 7.7).
Stability & Storage	Valid for 12 months from date of receipt when stored at -80°C. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Shipping	In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Research Background	Glypican-3 is a protein ,which is encoded by the GPC3 gene in humans.The protein core of GPC3 consists of two subunits, where the N-terminal subunit has a size of ~40 kDa and the C-terminal subunit is ~30 kDa.Glypican 3 is a potential therapeutic target for treating liver cancer and other cancers. Several therapeutic anti-GPC3 antibodies have been developed.